rewirebio.iobenchmarks
Protocol

Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction

AUC overall and within ichorCNA tumour-fraction strata on the 2,043-sample validation cohort used for model selection.

3 evaluations · 10 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

3 recorded evaluations, 10 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.

View coverage and remaining gaps across all benchmarks

Results

Results are available, but no reviewed comparison panel is linked in this release.

All evaluations

3 evaluations · 10 results. Different protocols are not a single leaderboard.

Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction · Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)

Sorted by AUROC (low-TF (< 3%) cancers vs non-cancer) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationAUROC (low-TF (< 3%) cancers vs non-cancer)AUROC (all cancers vs non-cancer)AUROC (high-TF (> 5%) cancers vs non-cancer)AUROC (medium-TF (3-5%) cancers vs non-cancer)Recall (sensitivity, all cancers, at the predefined cutoff (98% specificity in the training cohort))Recall (sensitivity, low-TF (< 3%) stage I/II cancers, at the predefined cutoff (98% specificity in the training cohort))Recall (sensitivity, low-TF (< 3%) stage III/IV cancers, at the predefined cutoff (98% specificity in the training cohort))
Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Evaluation0.884 (best in column)0.917 (best in column)Not reportedNot reported0.610.3970.683
Fragmentia-AI WGS, high/medium-TF sequential fine-tuningEvaluation0.702Not reportedNot reportedNot reportedNot reportedNot reportedNot reported
Fragmentia-AI WGS, high-TF-only fine-tuningEvaluation0.6520.7690.9880.905Not reportedNot reportedNot reported
All 10 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.884 AUROC (low-TF (< 3%) cancers vs non-cancer)
unitless · higher

Uncertainty: 95% CI 0.868 to 0.901. Method not stated

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P14, sentence 5
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.917 AUROC (all cancers vs non-cancer)
unitless · higher

Uncertainty: 95% CI 0.905 to 0.929. Method not stated

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P14, sentence 1
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.61 Recall (sensitivity, all cancers, at the predefined cutoff (98% specificity in the training cohort))
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P14, sentence 3
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.397 Recall (sensitivity, low-TF (< 3%) stage I/II cancers, at the predefined cutoff (98% specificity in the training cohort))
fraction · higher

Uncertainty: 95% CI 0.350 to 0.445. Method not stated

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Supplementary Table S4, row 'Validation' / 'I/II', column 'Sensitivity (95% CI)'
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.683 Recall (sensitivity, low-TF (< 3%) stage III/IV cancers, at the predefined cutoff (98% specificity in the training cohort))
fraction · higher

Uncertainty: 95% CI 0.594 to 0.763. Method not stated

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Supplementary Table S4, row 'Validation' / 'III/IV', column 'Sensitivity (95% CI)'
Configuration: Fragmentia-AI WGS, high/medium-TF sequential fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.702 AUROC (low-TF (< 3%) cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium-TF sequential fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 4
Configuration: Fragmentia-AI WGS, high-TF-only fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.988 AUROC (high-TF (> 5%) cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high-TF-only fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 2
Configuration: Fragmentia-AI WGS, high-TF-only fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.652 AUROC (low-TF (< 3%) cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high-TF-only fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 2
Configuration: Fragmentia-AI WGS, high-TF-only fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.905 AUROC (medium-TF (3-5%) cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high-TF-only fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 2
Configuration: Fragmentia-AI WGS, high-TF-only fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.769 AUROC (all cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high-TF-only fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 2

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Methods and evaluation design

Procedure, tasks and evaluated configurations

Recorded evaluations

Each evaluation records what was tested and under which conditions.

Baseline coverage

Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.

0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.

No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.

Author-reported evaluations
3

Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.

Null control

Proposed control: requires review

Select a task-valid null control after reviewing inputs and metric

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Conventional reference

Proposed control: requires review

Select an upstream conventional reference after reviewing the full protocol

Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.

This is a suggested selection rule, not a validated method or a measured score.

Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)

Coverage is derived from release 2026-11-21-adc15377fab2. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.

Run instructions

No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-fragmentiawgs2026-protocol-validation.

Source locator: Results P13-P14; Table S4

Related records

Suggest a correction